A revealing new study from Israel examines the association between COVID-19 vaccinations, infection rates, and emergency medical service callouts for cardiovascular events in people aged 16-39. Published in the Nature journal Scientific Reports, one of the world’s most influential science journals, the study found that an eye-opening increase of over 25 percent occurred in callouts for cardiac arrest and acute coronary syndrome during Israel’s initial COVID-19 vaccine rollout between January and May 2021.
Analysis of the data showed that emergency call counts for cardiovascular events were significantly associated with the rates of first and second vaccine doses given, but not with COVID-19 infection rates. The researchers say their findings raise concerns regarding vaccine-induced severe cardiovascular side-effects, adding that they underscore the already established causal relationship between vaccines and myocarditis, a frequent cause of unexpected cardiac arrest in young people.
The study points out that data from the Vaccine Adverse Events Reporting System (VAERS) in the United States, the Yellow Card reporting system in the United Kingdom, and the EudraVigilance system in Europe already associate myocarditis and other cardiovascular side effects with COVID-19 vaccines. Moreover, research carried out by the Ministry of Health in Israel – a country with one of the highest vaccination rates in the world – has assessed the risk of myocarditis after receiving a second COVID-19 vaccine dose to be somewhere between 1 in 3000 and 1 in 6000 for men aged 16 to 24. This means that for every 1 million second COVID-19 vaccinations given to men in this particular age group, up to 333 cases of myocarditis would be expected to occur.
The Israeli researchers conclude that the results of their study underscore the need for a thorough investigation of the association between COVID-19 vaccines and adverse cardiovascular outcomes in young adults, adding that this would be critical towards informing related public health policy and preventing potentially avoidable patient harm.
The publication of this latest research comes at a time when there is already growing concern over the health risks of COVID-19 vaccines. Along with inflammation of the heart muscle (myocarditis), previous studies have confirmed that the mRNA vaccines used against the SARS-CoV-2 virus can cause severe liver damage, very low platelet counts (thrombocytopenia), high rates of rates of severe, potentially life-threatening allergic reactions (anaphylaxis), blood clots (thrombosis), and even death. Given the serious nature of these risks, Dr. Matthias Rath has demanded that the use of RNA- and DNA-based COVID-19 vaccines should immediately now be suspended.
In contrast to the proven dangers of experimental COVID-19 vaccines, studies carried out at the Dr. Rath Research Institute in California have demonstrated that effective, completely safe alternative therapies for improving immunity now exist. In the most recent example of this research, a specific combination of natural plant extracts and micronutrients was found to be highly effective against the original SARS-CoV-2 virus and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. Together with the recently established clinical evidence that high-dose vitamin C can successfully combat COVID-19, even in its advanced stages, it is time for the use of these science-based natural health therapies to become standard medical practice.